• Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Receives Consensus Rating of "Moderate Buy" from Analysts

    Источник: Buzz FX / 01 фев 2025 02:51:09   America/New_York


    Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Receives Consensus Rating of "Moderate Buy" from Analysts Written by MarketBeat February 1, 2025 Share Link copied to clipboard. Madrigal Pharmaceuticals, Inc.
    Read more...
Опубликовать